PharmaSmart International, LLC is a leading company in the health care, manufacturing, and medical devices industries, based in Rochester, NY, USA. The company specializes in designing, producing, and distributing clinically validated blood pressure monitoring systems to aid in managing hypertension, obesity, and diabetes. PharmaSmart is renowned for providing products and services utilized by pharmacies, worksites, and medical clinics across North America, conducting over 65 million blood pressure screenings annually. Utilizing a patented, HIPAA Compliant Health IT process and advanced "Smart Card" technology, PharmaSmart's kiosks revolutionize biometric data management, supporting chronic disease awareness, prescription compliance, and physician reporting. The company's Blood Pressure Tracker™ web portal and integrated Health IT solutions offer a seamless process for accessing and sharing patient vitals through a turnkey interoperable platform. Founded in 2000, PharmaSmart is dedicated to enhancing the care provided by pharmacists. The company collaborates with community pharmacy partners to deliver an enrollment-based chronic disease management program, elevating the clinical standard for controlling blood pressure and driving new reimbursement models aligned with the Affordable Care Act. Additionally, PharmaSmart serves major worksites, military bases, University Schools of Pharmacy, hospitals, and medical clinics. Notably, PharmaSmart’s PS DataSmart® Health IT Server currently holds over 40 million targeted patient blood pressure readings while registering approximately 1,000,000 new readings monthly. The company's most recent investment, a Debt Financing, took place on 02 August 2023, with Private Debt Partners as the investors. With a strong track record and a clear commitment to advancing healthcare, PharmaSmart presents an intriguing opportunity for potential financial backing.
No recent news or press coverage available for PharmaSmart International, LLC.